CAS No. 675606-52-7

3,6,9,12-Tetraoxatetradecan-1-ol,14-[4-[(16-phenyl-3,6,9,12,15-pentaoxahexadec-1-yl)oxy]phenoxy]-

Catalog No.: 1746089
Name: 3,6,9,12-Tetraoxatetradecan-1-ol,14-[4-[(16-phenyl-3,6,9,12,15-pentaoxahexadec-1-yl)oxy]phenoxy]-
CAS: 675606-52-7
Formula: C33H52O12

Inquire about this product → | Safety data

About 3,6,9,12-Tetraoxatetradecan-1-ol,14-[4-[(16-phenyl-3,6,9,12,15-pentaoxahexadec-1-yl)oxy]phenoxy]-

3,6,9,12-Tetraoxatetradecan-1-ol,14-[4-[(16-phenyl-3,6,9,12,15-pentaoxahexadec-1-yl)oxy]phenoxy]- is a chemical compound registered under CAS number 675606-52-7, with the molecular formula C33H52O12 and a molecular weight of about 640.77 g/mol. 9CMX supplies 3,6,9,12-Tetraoxatetradecan-1-ol,14-[4-[(16-phenyl-3,6,9,12,15-pentaoxahexadec-1-yl)oxy]phenoxy]- for laboratory research and bulk production; product code 1746089. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 675606-52-7
Molecular Formula: C33H52O12
Molecular Weight: 640.77 g/mol

Related Keywords

phenoxy

pentaoxahexadec

tetraoxatetradecan

N-ethylbicyclo[3.1.0]hexan-2-amine ethanedioate

2-Naphthalenol, 1-[[(2,4,5-trichlorophenyl)imino]methyl]-

2H-Pyrido[3,2-b]-1,4-oxazine, 4-[(3-aminophenyl)sulfonyl]-3,4-dihydro-

8-bromo-7-butyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione

2H-Pyrido[3,2-b]-1,4-thiazin-3(4H)-one, 6-(chloroacetyl)-

2-Naphthalenol, 3,7-bis(1,1-dimethylethyl)-

663624-26-8

2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one,6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2,4-trimethyl-

2H-Pyrazolo[4,3-c]pyridine-7-carboxylic acid,3,5-dihydro-3-oxo-2-phenyl-5-pyrazinyl-, ethyl ester

3-[5,6-dimethoxy-1-(1,3,5-trimethyl-1H-pyrazole-4-sulfonyl)-1H-indol-3-yl]-propionic acid

2-Pyridinecarboxamide,N-[(1S)-3-[[(1S)-1-cyclohexyl-2-[(3R,4S)-4-methyl-2,5-dioxo-3-pyrrolidinyl]-2-oxoethyl]amino]-3-oxo-1-phenylpropyl]-6-fluoro-

2-Pyridinecarboxamide,4-methoxy-N-[2-[4-(2-phenylethyl)-1-piperidinyl]ethyl]-, ethanedioate(1:1)

2-Naphthalenol, 1-[[(3-iodophenyl)imino]methyl]-

398510-20-8

2H-Pyrido[3,2-b]-1,4-oxazine, 2-ethyl-3,4-dihydro-

2H-Pyrido[2,1-c][1,2,4]triazin-3(4H)-one, 6,7,8,9-tetrahydro-4-phenyl-

2H-Pyrazolo[3,4-c]quinoline-1-butanamine,4-amino-6,7,8,9-tetrahydro-2-propyl-, bis(trifluoroacetate)

2-Naphthalenesulfonic acid,7-[(5,6-difluoro-4-pyrimidinyl)amino]-4-hydroxy-3-[(4-methyl-2-sulfophenyl)azo]-

2-Naphthalenesulfonic acid,6-hydroxy-5-[[4-[(3-sulfophenyl)azo]-1-naphthalenyl]azo]-, disodium salt

2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one,6-[[2-[(3-chloro-4-methylphenyl)amino]-5-fluoro-4-pyrimidinyl]amino]-

662236-46-6

2-Naphthalenesulfonic acid,7-amino-4-hydroxy-3-[[4-[[2-hydroxy-4-[(8-quinolinylsulfonyl)amino]phenyl]azo]phenyl]azo]-

a-Amino-4-(Boc-amino)-benzeneacetic acid

2-Naphthalenol, 3-[(phenylamino)methyl]-

2-Pyridinecarboxamide,4-chloro-N-[2-[4-(2-phenylethyl)-1-piperidinyl]ethyl]-, dihydrochloride

2-Naphthalenol, 1-(2-amino-4-pyrimidinyl)-

2-Naphthalenol, 1-[(S)-phenyl[(2R)-2-phenyl-1-piperidinyl]methyl]-

667870-51-1

2-Naphthalenol, 1,2,3,4-tetrahydro-2-[(trimethylsilyl)methyl]-

2-(thiophen-2-ylmethylidene)hydrazinecarboxamide

2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one,6-[[2-[(3-chloro-4-methoxyphenyl)amino]-5-fluoro-4-pyrimidinyl]amino]-2-methyl-, (2S)-

5-(2-methoxyethyl)-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione

2-Pyridinecarboxamide,4-[[2-[(4-methoxyphenyl)amino]-1-methyl-1H-benzimidazol-5-yl]oxy]-N-methyl-

2-Naphthalenol, 1-[(2-hydroxy-4-methylphenyl)azo]-

51049-66-2

2-Naphthalenol, 3-(1-methylethyl)-

2-Naphthalenol, 3-[5-[(4-fluorophenyl)amino]-1,3,4-thiadiazol-2-yl]-

2-Naphthalenol, 1-bromo-3-(bromomethyl)-

2-Naphthalenol, 1-[phenyl[(E)-(phenylmethylene)amino]methyl]-

2H-Pyrido[3,2-b]indol-2-one,1,5-dihydro-5-methyl-1-[4-(5-propyl-1,2,4-oxadiazol-3-yl)phenyl]-

2H-Pyrazolo[3,4-d]pyridazine, 2-(4-methylphenyl)-7-phenyl-